Outcomes for patients with mantle cell lymphoma post-covalent BTK inhibitor therapy in the United States and Japan: a study of two real-world databases

2021

Rai S, Hess LM, Chen Y, Bowman L, Abada PB, Konig H, Walgren RA, Tanizawa Y, Cai Z, Tajimi M